Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · February 13, 2024

Intraocular Pressure–Related Effects of 0.19 mg Fluocinolone Acetonide Intravitreal Implant in Patients With Diabetic Macular Edema

Ophthalmology Retina


Additional Info

Disclosure statements are available on the authors' profiles:

Ophthalmology Retina
The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 Months
Ophthalmol Retina 2024 Jan 01;8(1)49-54, DB Roth, D Eichenbaum, D Malik, NM Radcliffe, A Cutino, KW Small

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading